Starting on Slide 5, 2025 marked the fifth year since our Board and management team formulated and began implementing our ...
Johnson & Johnson (NYSE: JNJ) (the "Company"), healthcare’s leading, most comprehensive innovation powerhouse, today announced a more than $1 billion investment in a next generation cell therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results